Go
Sort by:
titlesubmit dateissue date
Order:
ascendingdescending
Results:
51020406080100
Update
Now showing items 1-1 of 1
Results From the Phase III Randomized Trial of Onartuzumab Plus Erlotinib Versus Erlotinib in Previously Treated Stage IIIB or IV Non-Small-Cell Lung Cancer: METLung
journal article